Oligonucleotides, Antisense
"Oligonucleotides, Antisense" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Short fragments of DNA or RNA that are used to alter the function of target RNAs or DNAs to which they hybridize.
Descriptor ID |
D016376
|
MeSH Number(s) |
D13.150.480 D13.444.600.150.640 D13.695.578.424.480 D27.720.470.530.600.150.640
|
Concept/Terms |
Oligonucleotides, Antisense- Oligonucleotides, Antisense
- Antisense Oligonucleotides
- Anti-Sense Oligonucleotides
- Anti Sense Oligonucleotides
- Oligonucleotides, Anti-Sense
|
Below are MeSH descriptors whose meaning is more general than "Oligonucleotides, Antisense".
Below are MeSH descriptors whose meaning is more specific than "Oligonucleotides, Antisense".
This graph shows the total number of publications written about "Oligonucleotides, Antisense" by people in this website by year, and whether "Oligonucleotides, Antisense" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2009 | 0 | 1 | 1 |
2017 | 3 | 1 | 4 |
2018 | 2 | 2 | 4 |
2019 | 1 | 0 | 1 |
2020 | 1 | 2 | 3 |
2021 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Oligonucleotides, Antisense" by people in Profiles.
-
Cryo-EM and antisense targeting of the 28-kDa frameshift stimulation element from the SARS-CoV-2 RNA genome. Nat Struct Mol Biol. 2021 09; 28(9):747-754.
-
Efficient Inhibition of SARS-CoV-2 Using Chimeric Antisense Oligonucleotides through RNase L Activation*. Angew Chem Int Ed Engl. 2021 09 27; 60(40):21662-21667.
-
Fully automated fast-flow synthesis of antisense phosphorodiamidate morpholino oligomers. Nat Commun. 2021 07 20; 12(1):4396.
-
Synthesis and characterisation of N-gene targeted NIR-II fluorescent probe for selective localisation of SARS-CoV-2. Chem Commun (Camb). 2021 Jun 24; 57(51):6229-6232.
-
RNA-extraction-free nano-amplified colorimetric test for point-of-care clinical diagnosis of COVID-19. Nat Protoc. 2021 06; 16(6):3141-3162.
-
Potent and Selective Knockdown of Tyrosine Kinase 2 by Antisense Oligonucleotides. Immunohorizons. 2021 02 04; 5(2):70-80.
-
Gene editing and RNAi approaches for COVID-19 diagnostics and therapeutics. Gene Ther. 2021 06; 28(6):290-305.
-
RNA Drugs and RNA Targets for Small Molecules: Principles, Progress, and Challenges. Pharmacol Rev. 2020 10; 72(4):862-898.
-
Lipoprotein(a) Testing and Emerging Therapies. Cardiol Rev. 2020 Sep/Oct; 28(5):250-255.
-
Resolution of coronavirus disease 2019 (COVID-19). Expert Rev Anti Infect Ther. 2020 12; 18(12):1201-1211.